| German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients K Rahbar, H Ahmadzadehfar, C Kratochwil, U Haberkorn, M Schäfers, ... Journal of Nuclear Medicine 58 (1), 85-90, 2017 | 867 | 2017 |
| Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the … A Strangfeld, M Eveslage, M Schneider, HJ Bergerhausen, T Klopsch, ... Annals of the rheumatic diseases 70 (11), 1914-1920, 2011 | 426 | 2011 |
| PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall … K Rahbar, M Boegemann, A Yordanova, M Eveslage, M Schäfers, ... European journal of nuclear medicine and molecular imaging 45, 12-19, 2018 | 154 | 2018 |
| Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity M Liebmann, S Hucke, K Koch, M Eschborn, J Ghelman, AI Chasan, ... Proceedings of the National Academy of Sciences 115 (34), E8017-E8026, 2018 | 118 | 2018 |
| Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects L Klotz, M Eschborn, M Lindner, M Liebmann, M Herold, C Janoschka, ... Science Translational Medicine 11 (490), eaao5563, 2019 | 110 | 2019 |
| Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial C Weishaupt, A Strölin, B Kahle, A Kreuter, SW Schneider, J Gerss, ... The Lancet Haematology 3 (2), e72-e79, 2016 | 87 | 2016 |
| Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer K Rahbar, M Bögeman, A Yordanova, M Eveslage, M Schäfers, M Essler, ... European journal of nuclear medicine and molecular imaging 45, 243-246, 2018 | 84 | 2018 |
| HISTORY BEFORE DIAGNOSIS IN CHILDHOOD CRANIOPHARYNGIOMA: ASSOCIATIONS WITH INITIAL PRESENTATION AND LONG-TERM PROGNOSIS A Hoffmann, S Boekhoff, U Gebhardt, AS Sterkenburg, ... NEURO-ONCOLOGY 18, 18-18, 2016 | 81 | 2016 |
| History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis A Hoffmann, S Boekhoff, U Gebhardt, AS Sterkenburg, ... European Journal of Endocrinology 173 (6), 853-862, 2015 | 81 | 2015 |
| Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial S Ehrhardt, N Guo, R Hinz, S Schoppen, J May, M Reiser, MP Schroeder, ... Open forum infectious diseases 3 (1), ofw011, 2016 | 78 | 2016 |
| Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity C Lanvers-Kaminsky, JA Sprowl, I Malath, D Deuster, M Eveslage, ... Pharmacogenomics 16 (4), 323-332, 2015 | 76 | 2015 |
| Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007 K Heinks, S Boekhoff, A Hoffmann, M Warmuth-Metz, M Eveslage, J Peng, ... Endocrine 59, 364-372, 2018 | 71 | 2018 |
| The postoperative quality of life in children and adolescents with craniopharyngioma: results of a prospective multicenter study M Eveslage, G Calaminus, M Warmuth-Metz, RD Kortmann, F Pohl, ... Deutsches Ärzteblatt International 116 (18), 321, 2019 | 68 | 2019 |
| Corneal densitometry, central corneal thickness, and corneal central-to-peripheral thickness ratio in patients with Fuchs endothelial dystrophy M Alnawaiseh, L Zumhagen, G Wirths, M Eveslage, N Eter, A Rosentreter Cornea 35 (3), 358-362, 2016 | 68 | 2016 |
| Accelerated (18 mW/cm2) corneal collagen cross-linking for progressive keratoconus M Alnawaiseh, A Rosentreter, MRR Böhm, M Eveslage, N Eter, ... Cornea 34 (11), 1427-1431, 2015 | 64 | 2015 |
| Oxytocin in survivors of childhood-onset craniopharyngioma AMM Daubenbüchel, A Hoffmann, M Eveslage, J Özyurt, K Lohle, ... Endocrine 54, 524-531, 2016 | 60 | 2016 |
| Characteristics, risk factors and treatment reality in livedoid vasculopathy–a multicentre analysis C Weishaupt, A Strölin, B Kahle, A Kreuter, SW Schneider, J Gerss, ... Journal of the European Academy of Dermatology and Venereology 33 (9), 1784-1791, 2019 | 59 | 2019 |
| Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma A Bogusz, S Boekhoff, M Warmuth-Metz, G Calaminus, M Eveslage, ... Endocrine connections 8 (5), 481-492, 2019 | 59 | 2019 |
| Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: the AML-AZA trial of the study alliance leukemia C Müller-Tidow, P Tschanter, C Röllig, C Thiede, A Koschmieder, ... Leukemia 30 (3), 555-561, 2016 | 59 | 2016 |
| Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo) S Boekhoff, A Bogusz, AS Sterkenburg, M Eveslage, HL Müller European journal of endocrinology 179 (5), 331-341, 2018 | 56 | 2018 |
